Comparison of F-18 FET-PET with F-18 FDG-PET for biopsy planning of non-contrast-enhancing gliomas
- 3 June 2010
- journal article
- research article
- Published by Springer Nature in European Radiology
- Vol. 20 (10) , 2496-2502
Abstract
The management of non-contrast-enhancing brain tumours largely depends on biopsy, which allows a differentiation of low-grade gliomas (LGG) from high-grade gliomas (HGG). The aim of this study was to compare positron emission tomography using 2-[18F]-fluoro-2-deoxy-d-glucose (FDG-PET) and O-(2-[18F]-fluoroethyl)-l-tyrosine (FET-PET) in terms of providing target regions for biopsies.Keywords
This publication has 45 references indexed in Scilit:
- Comparison of 18F-FET and 18F-FDG PET in brain tumorsNuclear Medicine and Biology, 2009
- Surgical Target Selection in Cerebral Glioma Surgery: Linking Methionine (MET) PET Image Fusion and Neuronavigationmin - Minimally Invasive Neurosurgery, 2007
- Association between fluorine-18–labeled fluorodeoxyglucose uptake and 1p and 19q loss of heterozygosity in World Health Organization Grade II gliomasJournal of Neurosurgery, 2007
- O-(2-[18F]fluoroethyl)-l-tyrosine: uptake mechanisms and clinical applicationsNuclear Medicine and Biology, 2006
- O-(2-[18F]fluoroethyl)-L-tyrosine PET combined with MRI improves the diagnostic assessment of cerebral gliomasBrain, 2005
- Combined use of 18F-fluorodeoxyglucose and 11C-methionine in 45 positron emission tomography—guided stereotactic brain biopsiesJournal of Neurosurgery, 2004
- Stereotactic biopsy for intracranial lesions: reliability and its impact on the planning of treatmentActa Neurochirurgica, 2003
- Regional glucose metabolism and histopathology of gliomas: A study based on positron emission tomography-guided stereotactic biopsyCancer, 1996
- Correlation of glucose consumption and tumor cell density in astrocytomasJournal of Neurosurgery, 1993
- Positron Emission Tomography in the Detection of Malignant Degeneration of Low-Grade GliomasNeurosurgery, 1988